Description

BSE notifies listing of new securities issued by 10 companies under Employee Stock Option Plans (ESOP/ESOS), effective May 15, 2026. Companies include Amber Enterprises, Cyient, Dr. Lal Pathlabs, Federal Bank, and others.

Summary

BSE has notified trading members that further securities issued by 10 companies under Employee Stock Option Plans (ESOP/ESOS) are listed and admitted for trading effective Friday, May 15, 2026. The newly listed shares span companies across sectors including financial services, healthcare, chemicals, and technology. None of the shares are subject to a lock-in period.

Key Points

  • 10 companies have had new ESOP/ESOS shares listed for trading from May 15, 2026
  • All newly listed shares have no lock-in period (NA)
  • Meesho Limited has the largest allotment with 13,913,282 shares (face value ₹1)
  • Federal Bank has the second largest allotment with 229,887 shares
  • Shriram Finance and UTI Asset Management are also among the companies with fresh listings
  • Notice issued under Listing Operations department, Category: Company Related, Segment: Equity

Regulatory Changes

No regulatory changes. This is a routine operational notice under existing ESOP/ESOS listing framework.

Compliance Requirements

Trading members are requested to take note of the newly listed securities and update their systems accordingly to enable trading from May 15, 2026.

Important Dates

  • Notice Date: May 14, 2026
  • Effective Date for Trading: May 15, 2026 (Friday)

Impact Assessment

CompanyScrip CodeISINShares ListedFace Value (₹)
Amber Enterprises India Limited540902INE371P0101528,10010
Cyient Limited532175INE136B010203,1405
Dr. Lal Pathlabs Limited539524INE600L0102482,75010
Federal Bank Ltd.500469INE171A01029229,8872
Gokaldas Exports Ltd532630INE887G010273,4005
Meesho Limited544632INE0VDM0101513,913,2821
Nuvama Wealth Management Limited543988INE531F01023138,0992
Shriram Finance Limited511218INE721A01047144,1422
Sudarshan Chemical Indus. Ltd.506655INE659A0102315,6402
UTI Asset Management Company Limited543238INE094J010161,80010

The listings represent minor equity dilution for most companies. Meesho’s ~13.9 million share ESOP listing is the most significant in volume but given the ₹1 face value and the company’s total share base, the dilution impact remains limited. These are standard employee compensation-related listings with no material market disruption expected.

Impact Justification

Routine ESOP/ESOS listing notice affecting 10 companies with share dilution implications. Meesho's large allotment of ~13.9 million shares is notable, but overall this is a standard periodic listing event with no regulatory changes required.